ClearPoint Neuro Inc (NAS:CLPT)
$ 15.75 -0.73 (-4.43%) Market Cap: 434.46 Mil Enterprise Value: 436.72 Mil PE Ratio: 0 PB Ratio: 14.99 GF Score: 67/100

Clearpoint Neuro Inc at Stifel Healthcare Conference (Virtual) Transcript

Nov 16, 2021 / 03:40PM GMT
Release Date Price: $15.17 (-4.65%)
Mathew Justin Blackman
Stifel, Nicolaus & Company, Incorporated, Research Division - Analyst

Good morning, everybody. My name is Matt Blackman, I'm a member of the Stifel medtech research team. Thanks for joining us for our session with ClearPoint Neuro. Just by of way of quick background, ClearPoint Neuro is, it's roughly a $400 billion market cap company with a really interesting platform technology that provides stereotactic navigation, which facilitates minimally invasive surgical procedures in the brain under MRI guidance. Current applications of the system include electrode lead placement, placement of catheters and biopsy.

And the platform is also being used for the delivery of biologics, gene therapy, stem cell therapies to the brain. It's FDA cleared, CE marked. There are over 60 active clinical sites across the U.S., Canada and Europe. So a really exciting technology that I think everyone will look forward to hearing about. It's our pleasure to have Joe Burnett, the President and CEO; Danilo DâAlessandro, Chief Financial Officer. They're here to walk us through, as I said, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot